The biotechs work with the FDA to design trials but they choose their endpoints or at least that is my understanding. I have previously posted a video from RAC where the CEO was discussing trial design and how a lot of good drugs and therapies are lost because they fail trials due to poor trial design. Well worth a listen.
To be fair, things evolved quickly with treatments with covid and the patients and outcomes they were getting early were not the same as those in Phase 3 because of the different treatments the patients received prior to the trial. In a more normal situation, the patients would have been more homogenous as treatments don't normally evolve that quickly.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 01 Mar
The biotechs work with the FDA to design trials but they choose...
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online